News
BAYZF
60.00
+9.09%
5.00
Bayer's new unit for Roundup business sparks breakup speculation; Deutsche Bank raises to Buy
Seeking Alpha · 2d ago
Bayer upgraded to Buy from Hold at Deutsche Bank
TipRanks · 2d ago
Positive Report for Bayer (0P6S) from Deutsche Bank
TipRanks · 2d ago
Luke Bryan and One A Day® Launch Limited Edition Multivitamin Bottles Available Only at Walmart
Barchart · 2d ago
Bayer announces consolidation of U.S. glyphosate business into newly formed 'Ruveon LLC'
Seeking Alpha · 2d ago
Bayer Group announces consolidation of U.S. glyphosate business into Ruveon
TipRanks · 3d ago
Bayer names Alfonso Alba Ordóñez CEO of new U.S. glyphosate unit Ruveon
PUBT · 3d ago
BAYER AG - BAYER GROUP TO CONSOLIDATE U.S. GLYPHOSATE BUSINESS INTO DISTINCT ENTITY OPERATING AS RUVEON
Reuters · 3d ago
Ubben-Linked Trust Buys €1.19 Million in Bayer Shares
TipRanks · 3d ago
Jeffrey and Laura Ubben 2000 Trust, closely associated, buys Bayer shares worth EUR 1.19 million
PUBT · 3d ago
Bayer says EPA approves Convintro pre-emergent herbicide for US corn, soybean use
PUBT · 3d ago
Bayer removed from European Conviction List at Goldman Sachs
TipRanks · 3d ago
 Bayer seeks US duties on Chinese-made glyphosate, angering farmers
Reuters · 4d ago
FOCUS-Trump's push for the world's lowest drug prices hits snag with mid-sized companies
Reuters · 4d ago
Weekly Report: what happened at BAYZF last week (0622-0626)?
Weekly Report · 5d ago
Bayer (0P6S) Receives a Buy from DZ BANK AG
TipRanks · 06/27 12:25
Bayer: Supreme Court Win Does Not Make A Compounder
Seeking Alpha · 06/26 13:20
Bayer (0P6S) Receives a Buy from Barclays
TipRanks · 06/26 09:05
UBS Sticks to Its Buy Rating for Bayer (0P6S)
TipRanks · 06/26 06:25
Jefferies Sticks to Its Hold Rating for Bayer (0P6S)
TipRanks · 06/26 05:45
More
Webull provides a variety of real-time BAYZF stock news. You can receive the latest news about Bayer A G through multiple platforms. This information may help you make smarter investment decisions.
About BAYZF
Bayer AG is a German-based life science company. The Company's segments are Crop Science, Pharmaceuticals and Consumer Health. The Crop Science segment focuses on development, production and marketing of products in seeds and plant traits, crop protection, digital solutions and customer services to promote sustainable agriculture. The Pharmaceuticals segment focuses on prescription products, especially for cardiology and women's healthcare and specialty therapeutics focused on the areas of cardiology, oncology, hematology and ophthalmology, as well as gene therapy and others. The Consumer Health segment develops, produces and markets nonprescription over-the-counter medicines for self-medication. Its Consumer Health segment portfolio consists of products in dermatology, nutritional supplements, digestive health, allergy, cough and cold, and pain and cardiovascular risk prevention categories.